SCHEMBL3459105

SCHEMBL3459105

O=C(CCN1CCOCC1)C1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.43
KMT2A Q03164 6/20 0.42
ALDH1A1 P00352 6/20 0.42
MAPT P10636 5/20 0.42
MEN1 O00255 2/20 0.42
RAB9A P51151 1/20 0.40
HSP90AA1 P07900 1/20 0.40
TP53 P04637 1/20 0.40
ALDH3A1 P30838 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 2/20 0.39
MPI P34949 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11494596 0.86 ITGB3 (0.42) SMN1; SMN2KMT2AALDH1A1MAPTMEN1
SCHEMBL22878181 0.77 ATM (0.45) GLASMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL15362709 0.77 ALDH1A1 (0.61) SMN1; SMN2KMT2AALDH1A1MEN1L3MBTL1
Hydrochloric Acid SCHEMBL17271473 0.76 ALDH1A1 (0.45) GLASMN1; SMN2KMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL15352721 0.76 ALDH1A1 (0.60) SMN1; SMN2KMT2AALDH1A1MEN1L3MBTL1
SCHEMBL3021250 0.75 LMNA (0.56) SMN1; SMN2KMT2AALDH1A1MEN1LMNA
SCHEMBL7130431 0.74 GLA (0.46) GLASMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL2146806 0.72 ALDH1A1 (0.55) SMN1; SMN2KMT2AALDH1A1MEN1L3MBTL1
SCHEMBL2146803 0.72 ALDH1A1 (0.55) SMN1; SMN2KMT2AALDH1A1MEN1L3MBTL1
SCHEMBL3557649 0.72 GLA (0.44) GLASMN1; SMN2KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240447-A2 MORPHOLINE DERIVATES AS ANTIOBESITY AGENTS AstraZeneca AB (Publ) (SE) 2010-10-20 EP disclosed
WO-2009071678-A2 MORPHOLINE DERIVATIVES AS ANTIOBESITY AGENTS BIOVITRUM AB (PUBL) (SE) 2009-06-11 WO disclosed